Company Search:
Advanced Search
Sponsored Links
Regulus Therapeutics Incorporated Company Snapshot
Regulus Therapeutics Incorporated operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Regulus Therapeutics Incorporated with three other companies in this sector in the United States: Sigma Labs Inc (2016 sales of $966,422.00 ), Flex Pharma Inc ($1.01 million of which 100% was Consumer Operations), and Yield10 Bioscience Inc ($1.16 million of which 100% was Government Grants, License).

Sales Analysis. Sales fell dramatically in 2016: During the year ended December of 2016, sales at Regulus Therapeutics Incorporated were $1.19 million. This is a sharp decrease of 94.2% versus 2015, when the company's sales were $20.76 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Regulus Therapeutics Incorporated
  Stock Performance Chart for Regulus Therapeutics Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (12/15/2017): .95
(Figures in U.S. Dollars)
1 Week 4.9%   13 Weeks 3.3%  
4 Weeks -27.5%   52 Weeks -60.4%  
Regulus Therapeutics Incorporated Key Data:
  Ticker: RGLS Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 1,194,000
(Year Ending Jan 2017).
Employees: 97
  Currency: U.S. Dollars Market Cap: 98,757,390
  Fiscal Yr Ends: December Shares Outstanding: 103,955,147
  Share Type: Common Closely Held Shares: 11,204,030
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.